Is there a meaningful serum hepatitis B virus DNA cutoff level for therapeutic decisions in hepatitis B e antigen–negative chronic hepatitis B virus infection?
Papatheodoridis, George V., Manesis, Emanuel K., Manolakopoulos, Spilios, Elefsiniotis, Ioannis S., Goulis, John, Giannousis, John, Bilalis, Antonios, Kafiri, Georgia, Tzourmakliotis, Dimitrios, Archimandritis, Athanasios J.
Published in Hepatology (Baltimore, Md.) (01.11.2008)
Published in Hepatology (Baltimore, Md.) (01.11.2008)
Get full text
Journal Article